Announcement

Break Through Cancer has launched a collaborative cohort for a Phase 1 study of RMC-6236, a compound developed by Revolution Medicines that is designed to suppress multiple RAS proteins that […]

Learn how our LABS (Lustgarten Advancing Breakthrough Science) program fosters collaboration and accelerates breakthroughs in research from three of our six internationally renowned Lustgarten lab leaders — Tyler Jacks, PhD, […]

David Daniels In late 2021, David began experiencing pain in his upper abdomen that radiated to his back. Despite a colonoscopy and an upper endoscopy showing no abnormalities or disease, […]

Mary Louise Lopez Mary Louise Lopez lived an exceptional life. She was a dedicated elementary school teacher, a brilliant pianist, a seasoned world traveler, and a talented chef, but most […]

On December 12, Learn how our LABS (Lustgarten Advancing Breakthrough Science) program fosters collaboration and accelerates breakthroughs in research from three of our six internationally renowned Lustgarten lab leaders — […]

Ben and Marie Rosenberg For Ben Rosenberg and his wife Marie, charitable giving is more than just passion; it is a priority. And, when Ben’s business partner and long-time friend […]

With survival rates hovering around 13 percent five years after diagnosis, the need for innovative and effective pancreatic cancer treatment remains critical. The good news is the recent meeting of […]

On October 23, join internationally renowned cancer immunotherapy and translational research expert, Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center of the University of Pennsylvania for a […]